NEWS
EGFR Liquid has been approved as a companion diagnostic
July 31, 2020
On July 31, 2020, Ryo Matoba, the president of DNA Chip Research Inc., announced that its diagnostic program, “EGFR Liquid” has been approved in Japan by the Pharmaceuticals and Medical Devices Agency (PMDA) for the detection of the epidermal growth factor receptor (EGFR) gene in DNA derived from plasma or tumor tissue. “EGFR Liquid” is a minimally invasive and a highly sensitive liquid biopsy test to detect abnormal (mutated) DNAs even in small quantities in blood for targeted therapies of lung cancer(NSCLC).
>Read more